REQUEST A DEMO
Total
USD $0.00
Search more companies

Rasayan Drugs Private Limited (India)

Main Activities: Other Services (except Public Administration)
Full name: Rasayan Drugs Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Rasayan Drugs Private Limited is an unlisted company, incorporated on 03/11/1997. It has its registered office in the State of PN, India. Company's corporate identification number (CIN) is U99999PN1997PTC111662 and registration number is 111662. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
A-22/2, At Post Kondi, Chincholi Kati, Mohol, North Solapur
Solapur; Maharashtra; Postal Code: 441300

Contact Details: Purchase the Rasayan Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Rasayan Drugs Private Limited report to view the information.
Outstanding Shares:
Purchase the Rasayan Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Rasayan Drugs Private Limited report to view the information.
Incorporation Date:
November 03, 1997
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Rasayan Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-14.56%
Total operating revenue
-14.57%
Operating profit (EBIT)
-38%
EBITDA
-18.24%
Net Profit (Loss) for the Period
-37.41%
Total assets
-6.17%
Total equity
2.62%
Operating Profit Margin (ROS)
-0.77%
Net Profit Margin
-0.55%
Return on Equity (ROE)
-3.21%
Debt to Equity Ratio
-12.34%
Quick Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?